Mark S. Borja

597 total citations
18 papers, 469 citations indexed

About

Mark S. Borja is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Mark S. Borja has authored 18 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Mark S. Borja's work include Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers), Lipoproteins and Cardiovascular Health (3 papers) and Cholesterol and Lipid Metabolism (3 papers). Mark S. Borja is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers), Lipoproteins and Cardiovascular Health (3 papers) and Cholesterol and Lipid Metabolism (3 papers). Mark S. Borja collaborates with scholars based in United States, Norway and Australia. Mark S. Borja's co-authors include Michael N. Oda, John D. Gross, Kirill Piotukh, Christian Freund, Stephen N. Floor, Arthur P. Arnold, Karen Reue, Xuqi Chen, Jenny C. Link and Gregory C. Shearer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Mark S. Borja

18 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark S. Borja United States 14 197 151 145 77 52 18 469
Saleem Ullah Shahid Pakistan 13 88 0.4× 149 1.0× 89 0.6× 67 0.9× 54 1.0× 26 404
L. Perségol France 10 240 1.2× 113 0.7× 190 1.3× 77 1.0× 40 0.8× 14 409
Muralikrishna Gangadharan Komala Australia 9 351 1.8× 171 1.1× 166 1.1× 37 0.5× 45 0.9× 22 615
Jeffrey Rhyne United States 14 155 0.8× 171 1.1× 203 1.4× 73 0.9× 107 2.1× 16 487
Jordan Morningstar United States 12 124 0.6× 202 1.3× 132 0.9× 91 1.2× 90 1.7× 25 467
Valérie Guyard‐Dangremont France 8 267 1.4× 144 1.0× 251 1.7× 62 0.8× 35 0.7× 8 494
Jiecan Zhou China 10 226 1.1× 145 1.0× 85 0.6× 45 0.6× 52 1.0× 34 442
Andreas Melidonis Greece 10 112 0.6× 92 0.6× 92 0.6× 115 1.5× 52 1.0× 16 444
Ana Lorenzo-Almorós Spain 10 101 0.5× 177 1.2× 92 0.6× 270 3.5× 36 0.7× 10 526
Jane Wilkinson United Kingdom 13 148 0.8× 149 1.0× 156 1.1× 57 0.7× 31 0.6× 21 509

Countries citing papers authored by Mark S. Borja

Since Specialization
Citations

This map shows the geographic impact of Mark S. Borja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Borja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Borja more than expected).

Fields of papers citing papers by Mark S. Borja

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Borja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Borja. The network helps show where Mark S. Borja may publish in the future.

Co-authorship network of co-authors of Mark S. Borja

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Borja. A scholar is included among the top collaborators of Mark S. Borja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Borja. Mark S. Borja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Borja, Mark S., Chongren Tang, Olga V. Savinova, et al.. (2024). Effects of niacin and omega-3 fatty acids on HDL-apolipoprotein A-I exchange in subjects with metabolic syndrome. PLoS ONE. 19(2). e0296052–e0296052. 2 indexed citations
2.
Huang, Jiansheng, Patricia G. Yancey, Tao Huan, et al.. (2020). Reactive Dicarbonyl Scavenging Effectively Reduces MPO-Mediated Oxidation of HDL and Restores PON1 Activity. Nutrients. 12(7). 1937–1937. 14 indexed citations
3.
Zhang, Linda, John Melchior, Jamie Morris, et al.. (2019). Modified sites and functional consequences of 4-oxo-2-nonenal adducts in HDL that are elevated in familial hypercholesterolemia. Journal of Biological Chemistry. 294(50). 19022–19033. 13 indexed citations
4.
Heier, Martin, Anne Pernille Ofstad, Mark S. Borja, et al.. (2018). High-density lipoprotein function is associated with atherosclerotic burden and cardiovascular outcomes in type 2 diabetes. Atherosclerosis. 282. 183–187. 6 indexed citations
5.
Zhang, Linda, Jiansheng Huang, Mark S. Borja, et al.. (2018). Modification by isolevuglandins, highly reactive γ-ketoaldehydes, deleteriously alters high-density lipoprotein structure and function. Journal of Biological Chemistry. 293(24). 9176–9187. 37 indexed citations
6.
Sarzynski, Mark A., Jacob L. Barber, Cris A. Slentz, et al.. (2018). Effects of Increasing Exercise Intensity and Dose on Multiple Measures of HDL (High-Density Lipoprotein) Function. Arteriosclerosis Thrombosis and Vascular Biology. 38(4). 943–952. 44 indexed citations
7.
Heier, Martin, Mark S. Borja, Cathrine Brunborg, et al.. (2017). Reduced HDL function in children and young adults with type 1 diabetes. Cardiovascular Diabetology. 16(1). 85–85. 30 indexed citations
8.
Angelovich, Thomas A., Anna C. Hearps, Michael N. Oda, et al.. (2017). Dysfunctional high-density lipoprotein from HIV+ individuals promotes monocyte-derived foam cell formation in vitro. AIDS. 31(17). 2331–2336. 17 indexed citations
9.
Borja, Mark S., et al.. (2017). Apolipoprotein A-I exchange is impaired in metabolic syndrome patients asymptomatic for diabetes and cardiovascular disease. PLoS ONE. 12(8). e0182217–e0182217. 23 indexed citations
10.
Kelesidis, Theodoros, et al.. (2017). Predictors of Impaired HDL Function in HIV-1 Infected Compared to Uninfected Individuals. JAIDS Journal of Acquired Immune Deficiency Syndromes. 75(3). 354–363. 17 indexed citations
11.
Zhang, Linda, Tao Huan, Mark S. Borja, et al.. (2017). Abstract 208: Isolevuglandin, a Highly Reactive γ-ketoaldehyde Formed from the Isoprostane Pathway, Induces Deleterious Structural and Functional Consequences to High-density Lipoprotein. Arteriosclerosis Thrombosis and Vascular Biology. 37(suppl_1). 1 indexed citations
12.
Soupène, Eric, et al.. (2016). Featured Article: Alterations of lecithin cholesterol acyltransferase activity and apolipoprotein A-I functionality in human sickle blood. Experimental Biology and Medicine. 241(17). 1933–1942. 13 indexed citations
13.
Borja, Mark S., Angela D. Irwin, Daniel Isquith, et al.. (2015). HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity. Journal of Lipid Research. 56(10). 2002–2009. 39 indexed citations
14.
Link, Jenny C., Xuqi Chen, Mark S. Borja, et al.. (2015). Increased High-Density Lipoprotein Cholesterol Levels in Mice With XX Versus XY Sex Chromosomes. Arteriosclerosis Thrombosis and Vascular Biology. 35(8). 1778–1786. 73 indexed citations
15.
Borja, Mark S., Lei Zhao, Chongren Tang, et al.. (2013). HDL-apoA-I Exchange: Rapid Detection and Association with Atherosclerosis. PLoS ONE. 8(8). e71541–e71541. 50 indexed citations
16.
Oda, Michael N., Madhu S. Budamagunta, Mark S. Borja, et al.. (2013). The secondary structure of apolipoprotein A‐I on 9.6‐nm reconstituted high‐density lipoprotein determined by EPR spectroscopy. FEBS Journal. 280(14). 3416–3424. 17 indexed citations
17.
Floor, Stephen N., Mark S. Borja, & John D. Gross. (2012). Interdomain dynamics and coactivation of the mRNA decapping enzyme Dcp2 are mediated by a gatekeeper tryptophan. Proceedings of the National Academy of Sciences. 109(8). 2872–2877. 29 indexed citations
18.
Borja, Mark S., Kirill Piotukh, Christian Freund, & John D. Gross. (2010). Dcp1 links coactivators of mRNA decapping to Dcp2 by proline recognition. RNA. 17(2). 278–290. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saleem Ullah Shahid Breakdown of academic impact, for papers by L. Perségol Breakdown of academic impact, for papers by Muralikrishna Gangadharan Komala Breakdown of academic impact, for papers by Jeffrey Rhyne Breakdown of academic impact, for papers by Jordan Morningstar Breakdown of academic impact, for papers by Valérie Guyard‐Dangremont Breakdown of academic impact, for papers by Jiecan Zhou Breakdown of academic impact, for papers by Andreas Melidonis Breakdown of academic impact, for papers by Ana Lorenzo-Almorós Breakdown of academic impact, for papers by Jane Wilkinson
Rankless by CCL
2026